Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,037,000 | 2,772,000 | 4,718,000 | 6,085,000 | 5,705,000 |
| Marketable Securities | N/A | N/A | N/A | 1,179,000 | 1,159,000 |
| Receivables | 4,587,000 | 4,663,000 | 4,669,000 | 4,660,000 | 4,790,000 |
| Inventories | 1,869,000 | 2,026,000 | 1,853,000 | 1,787,000 | 1,663,000 |
| Other current assets | -1,000 | 0 | 1,000 | 0 | 1,000 |
| TOTAL | $14,779,000 | $12,317,000 | $14,041,000 | $16,085,000 | $15,980,000 |
| Non-Current Assets | |||||
| PPE Net | 5,391,000 | 5,346,000 | 5,321,000 | 5,317,000 | 5,572,000 |
| Investments And Advances | 0 | 0 | 0 | 1,163,000 | 1,156,000 |
| Intangibles | 28,860,000 | 31,146,000 | 31,742,000 | 34,768,000 | 35,466,000 |
| Other Non-Current Assets | 5,494,000 | 4,770,000 | 5,188,000 | 4,792,000 | 4,200,000 |
| TOTAL | $39,745,000 | $41,262,000 | $42,251,000 | $46,040,000 | $46,394,000 |
| Total Assets | $54,525,000 | $53,579,000 | $56,292,000 | $62,125,000 | $62,373,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,812,000 | 1,810,000 | 3,667,000 | 1,798,000 | 1,793,000 |
| Accounts payable and accrued liabilities | 903,000 | 537,000 | 622,000 | 550,000 | 586,000 |
| Accrued Expenses | 4,113,000 | 3,923,000 | 4,263,000 | 3,802,000 | 3,714,000 |
| Other current liabilities | 4,896,000 | 4,510,000 | 4,464,000 | 5,130,000 | 5,852,000 |
| TOTAL | $11,725,000 | $10,781,000 | $13,015,000 | $11,280,000 | $11,945,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,833,000 | 21,540,000 | 22,922,000 | 24,469,000 | 24,113,000 |
| aiOther Non-Current Liabilities | 782,000 | 2,156,000 | 1,967,000 | 2,051,000 | 2,096,000 |
| TOTAL | $24,409,000 | $24,603,000 | $25,822,000 | $28,096,000 | $28,185,000 |
| Total Liabilities | $36,135,000 | $35,382,000 | $38,837,000 | $39,376,000 | $40,131,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,246,266 | 1,244,992 | 1,245,853 | 1,245,775 | 1,246,042 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 11,073,000 | 11,165,000 | 10,656,000 | 16,304,000 | 16,002,000 |
| Other shareholders' equity | -11,000 | 9,000 | -15,000 | -56,000 | -40,000 |
| TOTAL | $18,390,000 | $18,197,000 | $17,455,000 | $22,749,000 | $22,242,000 |
| Total Liabilities And Equity | $54,525,000 | $53,579,000 | $56,292,000 | $62,125,000 | $62,373,000 |